Episode #35
E35 - Building the Future of Cell Therapy |Dr. Ron Cohen CEO of Oryon Cell Therapies
We are honored to welcome Dr. Ron Cohen, CEO of Oryon Cell Therapies and a distinguished leader in the biotechnology industry.With more than three decades of experience building innovative biotech companies, raising significant capital, and advancing therapies for patients, Dr. Cohen has made a lasting impact on the life sciences community.At Oryon Cell Therapies, he is leading the development of next-generation cell therapies with a focus on neurodegenerative diseases and the potential of regenerative medicine to address some of the most challenging conditions in healthcare.In this conversation, we explore his entrepreneurial journey, leadership lessons, biotech financing, the rapidly evolving field of cell therapy, and his vision for the future of regenerative medicine.Key Topics Discussed#Dr. Ron Cohen’s three-decade journey in biotechnology and entrepreneurship#What inspired him to pursue biotech rather than a traditional medical career#Lessons learned from setbacks and challenges throughout his entrepreneurial journey#His leadership philosophy and how it has evolved over the past 30 years#Why he joined Oryon Cell Therapies and his vision for its next chapter#The evolution of cell therapy and regenerative medicine#Scientific opportunities that were not possible just five years ago#What differentiates Oryon Cell Therapies in the regenerative medicine landscape#The potential of cell therapy in treating neurodegenerative diseases#Therapeutic areas where cell therapy could deliver major breakthroughs#Raising more than $1.1 billion in capital throughout his career#Advice for first-time biotech founders seeking investment#What investors look for in successful biotech CEOs beyond great science#Building resilient organizations and high-performance biotech teams#Creating a culture that thrives through both successes and setbacksEpisode Highlights#The Future of Cell Therapy — Exploring how advances in cell biology and regenerative medicine are opening new possibilities for treating complex diseases.#Neurodegenerative Diseases — Understanding the potential of next-generation cell therapies to address some of the most challenging neurological conditions.#Biotech Entrepreneurship — Dr. Cohen shares lessons from more than 30 years of building companies and advancing innovative therapies.#Raising Capital — Insights into biotech fundraising, investor expectations, and what founders need to demonstrate beyond compelling science.#Leadership & Culture — Practical lessons on building teams, navigating setbacks, and creating organizations capable of sustained innovation.#The Future of Biotechnology — Dr. Cohen shares his perspective on where cell therapy and regenerative medicine are heading and the opportunities that lie ahead.Whether you’re a biotech entrepreneur, scientist, physician, investor, pharmaceutical executive, cell therapy researcher, or healthcare innovator, this episode provides valuable perspectives on the science, business, and leadership shaping the next generation of biotechnology.Subscribe for conversations with leaders across biotechnology, pharmaceuticals, healthcare, clinical research, AI, cell therapy, and life sciences.#LifeScienceInsights360 #RonCohen #OryonCellTherapies #CellTherapy #Biotechnology #RegenerativeMedicine #NeurodegenerativeDiseases #Biotech #DrugDevelopment #LifeSciences #HealthcareInnovation #BiotechEntrepreneur #BiotechLeadership #VentureCapital #ClinicalResearch
